Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study

BMC Medicine(2013)10.1186/1741-7015-11-60Source: DataRank Database

Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study is a research paper published in BMC Medicine (2013). On theSindex it has a DataRank of 0.717. It has been cited 118 times.

N/A

0.717DataRank · unranked

Scored on demand from live citation data

Open Access118 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: goldTopics (22)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.717

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (24)

Christina Holzapfel ORCID,Xiao Dong ORCID,Erik Bader ORCID,Zhonghao Yu,Cornelia Prehn ORCID

Live enrichment

PubMed:19022398

European Commission

Grant: 242114

OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE)

goldLicense: cc-by

publisherhttps://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/1741-7015-11-60

publisherhttp://link.springer.com/content/pdf/10.1186/1741-7015-11-60.pdf

publisherhttp://link.springer.com/article/10.1186/1741-7015-11-60/fulltext.html

publisherhttp://link.springer.com/content/pdf/10.1186/1741-7015-11-60

publisherhttps://link.springer.com/content/pdf/10.1186/1741-7015-11-60.pdf

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Medicine(all)AdultAged, 80 and overMaleSerumSmoking610Middle Agedmetabolomicsmolecular epidemiology510smoking cessationCohort Studiesmetabolic networkMetabolomeHumansFemaleResearch ArticleAged

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts

10.6084/m9.figshare.23536128figshare

Additional file 1 of Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts

10.6084/m9.figshare.23536128.v1figshare